We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunoassay Assessed for Diagnosis of Norovirus Gastroenteritis

By LabMedica International staff writers
Posted on 14 Mar 2012
The sensitivity and specificity of a commercial Norovirus immunochromatographic test has been evaluated on human stool samples. More...


The immunochromatographic test is based on reverse transcription-polymerase chain reaction (RT-PCR) and the sensitive RT-nested PCR and was compared with another commercial real-time RT-PCR for detection of Norovirus in stool samples.

Scientists at Mahidol University (Bangkok, Thailand) tested 86 stool samples for noroviruses using the commercial immunochromatographic test RIDA QUICK Norovirus, which uses the biotin-streptavidin-peroxidase method. In addition, 54 Norovirus-positive samples from a second test group were also detected, and the copy number of Norovirus quantified by using a commercial real-time RT-PCR. Norovirus GI and GII antigens in stool samples can be detected using the RIDA QUICK Norovirus Test.

The sensitivity was analyzed using stool samples of the two test groups, which were confirmed for Norovirus infection by RT-PCR and RT-nested PCR, respectively. Based on the RT-PCR, the sensitivity of the RIDAQUICK Norovirus assay (R-Biopharm; Darmstadt, Germany) was 83.3% (15/18 samples), but compared with the RT-nested PCR, the sensitivity decreased to 48.2% (26/54 samples). The specificity of the assay was analyzed using Norovirus-negative stool samples from the control group and accounted for 87.5% (28/32 samples). The assay revealed false positives of 12.5%.

Among 23 stool samples showing Norovirus positive by both the RIDA QUICK Norovirus assay and the real-time RT-PCR (Shanghai ZJ Bio-Tech, Shanghai, China), the virus could be detected in samples taken on days 1–8 after onset of illness and these samples harbored Norovirus GII. The real-time RT-PCR for the simultaneous detection of Norovirus GI and GII and quantitation was completed on the LightCycler 1.5 Instrument Real Time PCR System (Roche Diagnostics, Mannheim, Germany). Viral ribonucleic acid (RNA) was extracted using the QIAam Viral RNA extraction kit (QIAGEN GmbH, Hilden, Germany).

The authors concluded that the RIDA QUICK Norovirus assay is rapid and simple to perform. The assay has high sensitivity and specificity. This method is appropriate to use for early diagnosis of acute gastroenteritis caused by noroviruses and for rapid screening of Norovirus infections in patients with acute gastroenteritis in both developed and developing countries where the RT-PCR method has not been established for routine diagnosis. However, negative results where Norovirus is strongly suspected should be further tested by more sensitive molecular techniques.

The study was published online on February 23, 2012, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
Mahidol University
R-Biopharm
Roche Diagnostics




New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.